Navigation Links
Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products

Technology to Drive Production Efficiency and Manage Quality at New LIFE Nutrition Factory in Germany

OFFENBACH, Germany, May 27 /PRNewswire-FirstCall/ -- Honeywell (NYSE: HON) today announced that it has been selected by B. Braun, a leading global manufacturer of healthcare products, to provide process control solutions for a new factory that will produce clinical nutrition and infusion therapy solutions. The Leading Infusion Factory Europe (LIFE) Nutrition plant, now under construction in Melsungen, Germany, is designed to enable B. Braun to double production capacity of these life-critical products.

Honeywell's Experion(R) Process Knowledge System (PKS) will be used at the LIFE Nutrition site to control production processes, optimize production output and maintain quality control standards. This is the second significant project undertaken by Honeywell for B. Braun; four years ago Honeywell was involved in the development of B. Braun's LIFE1 factory.

"Honeywell's proven technology and experience with LIFE1 made it the obvious choice for the LIFE Nutrition project, which represents an important and significant expansion of our business," said Thomas Gaebler, Vice President Global Process Engineering for B. Braun. "The pharmaceutical and batch features within Experion PKS combined with Honeywell's ability to execute specific applications fit our requirements perfectly. We have also had strong service in the past from Honeywell's seasoned and skilled local team."

B. Braun will use Honeywell's Experion as the centerpiece of the LIFE Nutrition factory's production system. Experion streamlines production by allowing plants to unify process, production and business management. The system ties together critical plant subsystems, including process units and safety systems, and delivers relevant information directly to operators for improved decision making in the control room.

Working in tandem with the Experion system, Honeywell's Qualification and Version Control System will simplify system configuration by allowing B. Braun's plant operators to electronically manage and maintain the control modules. Meanwhile, Experion Batch Manager's embedded batch functionality will allow B. Braun to execute batches at the control level rather than using a separate server, making the system more reliable, less complex and easier to maintain. In addition, Honeywell's Uniformance(R) PHD will help provide a flexible environment for the collection, storage and analysis of process data. The PHD architecture allows data to be gathered from disparate control systems into a unified database for long-term storage. Finally, Honeywell will provide B. Braun with a wide range of project management services and system training courses.

"The construction of the LIFE Nutrition plant will allow B. Braun to focus on producing world-class life-saving treatments," said Edwin van den Maagdenberg, vice president and general manager for Honeywell Process Solutions Europe, Middle East and Africa. "The manufacture of clinical nutrition and infusion therapy products is extremely complex and requires the right technology to do the job. Our experience in pharmaceuticals and existing customer knowledge will enable B. Braun to concentrate less on the manufacturing processes and more about growing their global business."

For more information about Experion and other Honeywell solutions that improve business performance, visit

Honeywell International ( is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell's shares are traded on the New York, London, and Chicago Stock Exchanges. For more news and information on Honeywell, please visit Honeywell Process Solutions is part of Honeywell's Automation and Control Solutions group, a global leader in providing product and service solutions that improve efficiency and profitability, support regulatory compliance, and maintain safe, comfortable environments in homes, buildings and industry. For more information about Process Solutions, access

This release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements are based on management's assumptions and assessments in light of past experience and trends, current conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by our forward-looking statements. Our forward-looking statements are also subject to risks and uncertainties, which can affect our performance in both the near- and long-term. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.

Experion(R) and Uniformance(R) are registered trademarks of Honeywell International Inc.

SOURCE Honeywell
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Honeywell HomMed Wins 2008 Medical Design Excellence Award for Genesis DM Remote Care Device
2. Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support
3. Honeywell Technology Selected to Control Manufacturing Processes at Major U.S. Biotech Site
4. B. Braun Technology Wins Novation Specialty Infusion Pumps Contract Award
5. B. Braun Directors Participate at First ISMP National Smart Pump Safety Summit
6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
7. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
8. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
9. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
10. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
11. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... Nov. 24, 2015  Asia-Pacific (APAC) holds the ... (CRO) market. The trend of outsourcing to low-cost ... but higher volume share for the region in ... however, margins in the CRO industry will improve. ... ( ), finds that the market ...
(Date:11/24/2015)... 24, 2015 Cepheid (NASDAQ: CPHD ) ... the following conference, and invited investors to participate via ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ... New York, NY      Tuesday, December 1, ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
Breaking Biology Technology:
(Date:11/18/2015)... PHILADELPHIA , Nov. 18, 2015  As new ... in children, doctors and other healthcare providers face challenges ... counsel families and patients. In addition, as more children ... into a patient,s adulthood and old age. ... The Children,s Hospital of Philadelphia (CHOP) . ...
(Date:11/17/2015)... EASTON, Mass. , Nov. 17, 2015 ... a leader in the development and sale of broadly ... the worldwide life sciences industry, today announced it has ... of its $5 million Private Placement (the "Offering"), increasing ... to $4,025,000.  One or more additional closings are expected ...
(Date:11/11/2015)...   MedNet Solutions , an innovative SaaS-based eClinical technology ... pleased to announce that it will be a Sponsor of ... to be held November 17-19 in Hamburg ... of iMedNet , MedNet,s easy-to-use, proven and ... has been able to deliver time and cost savings of ...
Breaking Biology News(10 mins):